Trump administration moves to reschedule marijuana from Schedule I to Schedule III and signs executive order on psychedelics research
Acting Attorney General Todd Blanche signed an order moving state-approved medical marijuana from Schedule I to Schedule III under the Controlled Substances Act. The change allows state-licensed medical marijuana suppliers to deduct standard business expenses on federal taxes and facilitates research, but does not legalize marijuana. Separately, Trump signed an executive order loosening research restrictions on psychedelic medicine.
60
Divergence score
This event sits in the top 1% of divergence this week. 6 outlets covered it, splitting into 6 framing camps across 2 bias groups.
6 camps
2 bias groups
The spectrum · how 6 outlets placed this story
LeftCenterRight
The Hill
Reason
Politico
NY Post
Washington Examiner
Reuters
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
Coverage splits between patient access wins and industry regulatory uncertainty, with outlets tracking both the rescheduling rollout and a looming hemp ban, while critics still warn of dangerously wrong messages on drug policy.
How each outlet covered it
Only the right is covering this
One side of the spectrum has stayed silent. That absence is itself a signal.
0
LEFT OUTLETS
0 of 6 outlets covering this story sit on that side of the spectrum.
0LEFT OUTLETS
THE RIGHT
“Medical Marijuana Rescheduling Is Legally Puzzling but a 'Huge Win' for Patients, Suppliers, and Scientists”R Reason RIGHT-CENTER
DOWN THE MIDDLE
“Trump moves to reschedule marijuana” · The Hill, Politico, Reuters
+Hide the full sourcingSee how all 6 outlets put it
CENTER3
HThe Hill Trump's Rogan-inspired psychedelics order stokes cautious optimism 59d ago PPolitico Trump moves to reschedule marijuana 58d ago RReuters US DEA medical marijuana registration portal to launch Wednesday 55d ago Tracked claims from across the political spectrum
Fact ledger
Corroborated
Disputed